Skip to content

A randomised controlled trial of the non-inferiority of Infraspinatus-teres minor interfascial block vs. interscalene brachial plexus block in patients undergoing arthroscopic shoulder surgery w

A randomised controlled trial of the non-inferiority of Infraspinatus-teres minor interfascial block vs. interscalene brachial plexus block in patients undergoing arthroscopic shoulder surgery with general anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084716
Enrollment
Unknown
Registered
2024-05-23
Start date
2024-05-29
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perioperative and postoperative analgesia for rotator cuff injury

Interventions

Infraspinatus-teres minor (ITM) interfascial block group:Infraspinatus-teres minor (ITM) interfascial block

Sponsors

NanJing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Selected for arthroscopic surgery, age between 18- 65 years, American Society of Anesthesiologists physical status I-III, BMI 18-35 kg/m^2.

Exclusion criteria

Exclusion criteria: Patients with severe lung disease, contraindications for experimental intervention, dependence on opioid drugs or use for more than 3 months, dementia, language disorders, or neurological and psychiatric disorders, surgical limb accompanied by neuropathy, cervical disc herniation, or cervical spondylosis.

Design outcomes

Primary

MeasureTime frame
Number of cases with rebound tenderness at 24 hours postoperatively;Number of cases with NRS score>=4 at 24 hours postoperativel;Number of cases requiring rescue analgesia within 24 hours postoperatively;QoR-15 scores on the day before surgery and at 24 h postoperatively;Number of cases with dyspnea within 24 hours postoperatively;

Secondary

MeasureTime frame
Pain NRS scores at 1, 6, 24 and 48 hours postoperatively;Oxycodone consumption postoperatively at 24 and 48 hours postoperatively;Extubation time;Length of stay in PACU;

Countries

China

Contacts

Public ContactZhang Yong

NanJing First Hospital

zhangyongjxz@163.com+86 13770557940

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026